What You Need to Know About the New Hepatitis C Test
July 12, 2024
July 12, 2024
ALEXANDRIA, Virginia, July 12 (TNSres) -- The Prevent Cancer Foundation issued the following news:
In June, the Food and Drug Administration (FDA) approved the first-ever point-of-care test to diagnose hepatitis C infection in adults. The Cepheid Xpert HCV test, which uses a fingertip blood sample, will make testing for hepatitis C--a leading cause of liver cancer--more accessible and faster for millions of people in the U.S. Here's what you need to know about the test.
. . .
In June, the Food and Drug Administration (FDA) approved the first-ever point-of-care test to diagnose hepatitis C infection in adults. The Cepheid Xpert HCV test, which uses a fingertip blood sample, will make testing for hepatitis C--a leading cause of liver cancer--more accessible and faster for millions of people in the U.S. Here's what you need to know about the test.
. . .